Experimental use of an extracellular matrix graft in pterygium surgery

Erik W. Anderson, Suri Dwarakanathan, Ramez Haddadin

Research output: Contribution to journalArticle

Abstract

A 40-year-old man presented with a primary pterygium of the right eye and underwent pterygium excision using mitomycin C and placement of an extracellular matrix (ECM) adjuvant. As an adjuvant in pterygium surgery, ECM serves as a scaffold while promoting the growth of normal conjunctiva. Perioperatively, the ECM graft was found to be easily manipulated on the surgical field. It attached to the scleral bed with fibrin glue without complication. Postoperatively, there was no inflammation or local tissue reaction to the porcine ECM graft. At the most recent follow-up examination, 6 months postoperatively, there were no signs of recurrence of the pterygium past the limbus. This is the first report describing the use of ECM as an adjuvant to pterygium excision.

Original languageEnglish (US)
Pages (from-to)15-17
Number of pages3
JournalDigital journal of ophthalmology : DJO
Volume23
Issue number4
DOIs
StatePublished - Jan 1 2017

Fingerprint

Pterygium
Extracellular Matrix
Transplants
Fibrin Tissue Adhesive
Conjunctiva
Mitomycin
Swine
Inflammation
Recurrence
Growth

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Anderson, Erik W. ; Dwarakanathan, Suri ; Haddadin, Ramez. / Experimental use of an extracellular matrix graft in pterygium surgery. In: Digital journal of ophthalmology : DJO. 2017 ; Vol. 23, No. 4. pp. 15-17.
@article{813729cbcc3f4be6bf848bc3950dee8f,
title = "Experimental use of an extracellular matrix graft in pterygium surgery",
abstract = "A 40-year-old man presented with a primary pterygium of the right eye and underwent pterygium excision using mitomycin C and placement of an extracellular matrix (ECM) adjuvant. As an adjuvant in pterygium surgery, ECM serves as a scaffold while promoting the growth of normal conjunctiva. Perioperatively, the ECM graft was found to be easily manipulated on the surgical field. It attached to the scleral bed with fibrin glue without complication. Postoperatively, there was no inflammation or local tissue reaction to the porcine ECM graft. At the most recent follow-up examination, 6 months postoperatively, there were no signs of recurrence of the pterygium past the limbus. This is the first report describing the use of ECM as an adjuvant to pterygium excision.",
author = "Anderson, {Erik W.} and Suri Dwarakanathan and Ramez Haddadin",
year = "2017",
month = "1",
day = "1",
doi = "10.5693/djo.02.2017.11.001",
language = "English (US)",
volume = "23",
pages = "15--17",
journal = "Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary",
issn = "1542-8958",
publisher = "Massachusetts Eye and Ear Infirmary",
number = "4",

}

Experimental use of an extracellular matrix graft in pterygium surgery. / Anderson, Erik W.; Dwarakanathan, Suri; Haddadin, Ramez.

In: Digital journal of ophthalmology : DJO, Vol. 23, No. 4, 01.01.2017, p. 15-17.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Experimental use of an extracellular matrix graft in pterygium surgery

AU - Anderson, Erik W.

AU - Dwarakanathan, Suri

AU - Haddadin, Ramez

PY - 2017/1/1

Y1 - 2017/1/1

N2 - A 40-year-old man presented with a primary pterygium of the right eye and underwent pterygium excision using mitomycin C and placement of an extracellular matrix (ECM) adjuvant. As an adjuvant in pterygium surgery, ECM serves as a scaffold while promoting the growth of normal conjunctiva. Perioperatively, the ECM graft was found to be easily manipulated on the surgical field. It attached to the scleral bed with fibrin glue without complication. Postoperatively, there was no inflammation or local tissue reaction to the porcine ECM graft. At the most recent follow-up examination, 6 months postoperatively, there were no signs of recurrence of the pterygium past the limbus. This is the first report describing the use of ECM as an adjuvant to pterygium excision.

AB - A 40-year-old man presented with a primary pterygium of the right eye and underwent pterygium excision using mitomycin C and placement of an extracellular matrix (ECM) adjuvant. As an adjuvant in pterygium surgery, ECM serves as a scaffold while promoting the growth of normal conjunctiva. Perioperatively, the ECM graft was found to be easily manipulated on the surgical field. It attached to the scleral bed with fibrin glue without complication. Postoperatively, there was no inflammation or local tissue reaction to the porcine ECM graft. At the most recent follow-up examination, 6 months postoperatively, there were no signs of recurrence of the pterygium past the limbus. This is the first report describing the use of ECM as an adjuvant to pterygium excision.

UR - http://www.scopus.com/inward/record.url?scp=85043383126&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85043383126&partnerID=8YFLogxK

U2 - 10.5693/djo.02.2017.11.001

DO - 10.5693/djo.02.2017.11.001

M3 - Article

C2 - 29403336

AN - SCOPUS:85043383126

VL - 23

SP - 15

EP - 17

JO - Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary

JF - Digital journal of ophthalmology : DJO / sponsored by Massachusetts Eye and Ear Infirmary

SN - 1542-8958

IS - 4

ER -